Samsung Bioepis' Imraldi® (Adalimumab) Recommended for Approval by European Medicines Agency
Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Imraldi®, a biosimilar candidate referencing Humira®1(adalimumab), for rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis, pediatric plaque psoriasis, adult and adolescent hidradenitis suppurativa, Crohn’s disease, pediatric Crohn’s disease, ulcerative colitis and uveitis.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170623005242/en/
Samsung Bioepis headquarters in Incheon, Korea. (Photo: Business Wire)
The CHMP’s positive opinion will now be referred to the European Commission (EC) which will review and decide on the grant of a marketing authorization for Imraldi®. If a marketing authorization is granted by the EC, Imraldi® will be commercialized in the European Union (EU) by Biogen.
“We welcome the EMA’s positive recommendation for Imraldi, which brings us a step closer to delivering a lower-cost, high-quality autoimmune treatment option to patients across Europe,” said Christopher Hansung Ko, President & CEO of Samsung Bioepis. “Through relentless process innovation and an uncompromising commitment to quality, we remain dedicated to advancing one of the industry's strongest biosimilar pipelines, so that more patients and healthcare systems across Europe will benefit from biosimilars.”
The Marketing Authorization Application (MAA) for Imraldi® was based on data derived from a randomized, double-blind 52-week Phase III study, in which 544 patients with moderate to severe rheumatoid arthritis despite methotrexate (MTX) therapy were randomized to receive either Imraldi® or the adalimumab reference product (ADL). At Week 24, the ACR20 response rate was 72.4% in the Imraldi® group versus 72.2% in the ADL group. The safety profile of Imraldi® was comparable to ADL up to Week 24. At Week 24, 254 patients receiving ADL were re-randomized in a 1:1 ratio to continue on ADL or switch to Imraldi®, and 254 patients receiving SB5 continued to receive SB5. Up to Week 52, the efficacy, safety and immunogenicity profiles remained comparable between all three treatment groups. There were no treatment emergent issues or clinically relevant immunogenicity precipitated by switching from ADL to Imraldi®.
About Samsung Bioepis Co., Ltd.
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that includes six first-wave candidates that cover the therapeutic areas of immunology, oncology and diabetes. Samsung Bioepis is a joint venture between Samsung BioLogics and Biogen. For more information, please visit: www.samsungbioepis.com.
1 Humira ® is a registered trademark of AbbVie Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170623005242/en/
Contact information
Samsung Bioepis Co., Ltd.
Mingi Hyun
+82-31-8061-1594
mingi.hyun@samsung.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cooler Master Brings MasterHUB to Europe: Modular Control Built on FreeForm 2.0 Principles20.5.2025 06:50:00 EEST | Press release
Cooler Master, a global leader in innovative thermal solutions and PC hardware, today announced MasterHUB will be available across Europe at the end of May. Built for streamers, content creators, and gamers, MasterHUB combines modular hardware, intuitive controls, and a customisable software suite—all grounded in Cooler Master’s FreeForm 2.0 design philosophy. With easily swappable modules, flexible layouts, and personalisation options to support a wide range of workflows, MasterHUB represents one of the most adaptable products Cooler Master has ever released. From live streaming and video editing to sound mixing and productivity automation, MasterHUB adapts to how users work—not the other way around. “MasterHUB reflects our FreeForm 2.0 approach—giving users the tools and freedom to shape their own experience,” said Jimmy Sha, Cooler Master CEO. “It’s more than a controller. It’s a platform that evolves with the creator, their tools, and their style.” Key Features: Modular, Reconfigur
Cooler Master Brings the Hyper 212 Pro to European Markets20.5.2025 06:50:00 EEST | Press release
Cooler Master, a global leader in innovative thermal solutions and PC hardware, today announced today announced the Hyper 212 PRO is now available in European markets. Building on the legacy of the Hyper 212 series, the PRO model features a redesigned tower layout, improved memory compatibility, and a refined aesthetic—all at an accessible price point. The Hyper 212 PRO is designed for builders looking to get the most out of their CPU without the complexity of liquid cooling. It delivers up to 230W TDP performance in a sleek, all-black package built to integrate easily into nearly any system configuration. “The Hyper 212 PRO shows how far air cooling has come—and how much more we can offer through design improvements,” said Jimmy Sha, CEO of Cooler Master. “We’re excited to bring this model to our European customers looking for reliable, high-performance thermal solutions.” Key Features: 230W Thermal Capacity — Efficiently cools modern high-core-count CPUs for consistent, long-term per
Cooler Master Launches FreeForm 2.0, Reinventing Customization for a New Generation20.5.2025 01:12:00 EEST | Press release
Cooler Master, a global leader in innovative thermal solutions and PC hardware, today announced FreeForm 2.0, a comprehensive design initiative built upon the company's legacy of personalization, modularity, and innovation. Inspired by Cooler Master's iconic "Make It Yours" heritage, FreeForm 2.0 emphasizes customization and adaptability across its range of products, empowering people to build systems that reflect their personal style. Custom. Open. Personal. These words define the future of how Cooler Master is designing products—and how users can expect to interact with them. "At Cooler Master, we believe technology should reflect the user, not the other way around," said Jimmy Sha, CEO of Cooler Master. "FreeForm 2.0 embodies this belief, giving our community the tools to customize, adapt, and reimagine their tech like never before." Customization Wherever Possible FreeForm 2.0 is more than a product series—it's an evolving ecosystem. The initiative spans multiple Cooler Master prod
Cooler Master Unveils the Future of Cooling During Computex 202520.5.2025 01:10:00 EEST | Press release
Cooler Master, a global leader in innovative thermal solutions and PC hardware, today announced its plans for its “One Cooler Master — Where Cooling Drives the Future” showcase at its headquarters during Computex. By pairing its vertically integrated enterprise arm with its consumer division, the company is demonstrating how innovations perfected for business quickly translate into more powerful, and more customizable hardware for consumer use. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519802170/en/ One Cooler Master — Where Cooling Drives the Future “Our structure allows ideas to flow in both directions — from the most demanding servers to the most expressive desktop rigs,” said Jimmy Sha, CEO of Cooler Master. “Everything on display at our headquarters began as a problem we solved for an enterprise partner or a creator. ‘One Cooler Master’ is about turning those lessons into products for everyone.” Visitors to Cool
Loomis Sayles Announces Changes to Disciplined Alpha Team19.5.2025 22:19:00 EEST | Press release
Loomis, Sayles & Company, the global investment manager with nearly $390 billion in assets under management as of 31 March 2025, has announced that Lynne Royer, co-head and portfolio manager of the Disciplined Alpha Team, will retire at the end of 2025 following a remarkable investment career spanning four decades. Additionally, longtime portfolio manager Brad Stevens, CFA, has been promoted to co-head of the team alongside Lynne and Seth Timen, who has co-led the team since 2021. Known for an intense focus on relative value investing and a proprietary risk-adjusted framework for making security selection decisions, the Disciplined Alpha Team manages over $22 billion in assets as of 31 March 2025. Lynne will step down from her portfolio management and team co-head roles in October 2025 and will serve as senior advisor to the team through the end of December. Brad and Seth will work closely together on the oversight of Disciplined Alpha portfolios, as well as management of the team, lev
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom